CAMERON CHAN: Open Payments
NPI 1326440660 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,450 in 161 payments from 34 companies in 2025. Trend: 2023 $2,521 · 2024 $2,852 · 2025 $3,450
Food & beverage: $3,405Education: $45
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $440 |
| UCB, Inc. | 24 | $435 |
| ABBVIE INC. | 16 | $268 |
| Neurelis, Inc. | 20 | $226 |
| Novo Nordisk Inc | 8 | $205 |
| Axsome Therapeutics, Inc. | 3 | $178 |
| Teva Pharmaceuticals USA, Inc. | 7 | $157 |
| Indivior Inc. | 8 | $157 |
| Verity Pharmaceuticals Inc. | 5 | $150 |
| Neurocrine BioSciences, Inc. | 7 | $150 |
Products named: FANAPT, VALTOCO, Briviact, VRAYLAR, Auvelity, SUBLOCADE, Tlando, INGREZZA.
Industry payments across CA — which companies pay providers there.
